FDA Inspection 1200437 — IMANI

IMANI — FEI 3018159965

The FDA completed an inspection of IMANI on March 22, 2023 in Yongin-Si. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 22, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Yongin-Si (Korea (the Republic of))

Citations

IDCFRDescription
323921 CFR 820.72(b)Remedial action - documentation